Wearable Shoe Device to Improve Walking and Activity in Peripheral Neuropathy
Tests a wearable foot device for walking and activity in adults with peripheral neuropathy.
Key facts
- Who runs it
- RxFunction Inc.
- Where
- Jacksonville, United StatesSee the site
- Trial code
- Registry title
- Wearable Sensory Prosthesis to Improve Coordination, Walking, and Physical Activity
- Status
- Recruiting
- People taking part
- 18 people, planned
- Started
- 25 Jun 2026
- Expected to end
- Dec 2027
- Type of study
- Interventional
- Treatments tested
- External, lower limb sensory prosthesis
- Record updated
- 25 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 60 or older with peripheral neuropathy and loss of feeling in the sole of the foot, who have balance problems and can walk 6 minutes without an assistive device.
- Age
- 60 years or older
- Sex
- All sexes can join.
- Disease stage
- Peripheral neuropathy (PN) with loss of feeling in the sole of the foot and balance impairment (Single-Leg Stance time of <23 seconds).
Main reasons for not taking part
- Under 60 years old
- Acute thrombophlebitis, including deep vein thrombosis, or severe peripheral vascular disease (self-reported)
- Untreated lymphedema, or an untreated lesion, swelling, infection or inflamed skin on the lower leg near where the device is used
- Other nerve or muscle and bone conditions that moderately or severely affect walking
- Weight of more than 300 pounds (136 kg)
The registry criteria, word for word
Show all 18 criteriaShow less
Who can take part
- Be 60 years of age or older
- Have a diagnosis of PN with plantar sensory loss
- Demonstrate balance impairment, defined as a Single-Leg Stance time of <23 seconds
- Be able to walk independently for at least 6 minutes without the use of an assistive device (rest breaks permitted)
- Be willing to use the Walkasins device as recommended
- Be willing to participate in all aspects of physical activity monitoring and study assessments
Who cannot take part
- Self-reported acute thrombophlebitis, including deep vein thrombosis
- Self-reported severe peripheral vascular disease
- Untreated lesion of any kind, swelling, infection, inflamed area of skin or eruptions on the lower leg near product use
- Other neurological or musculoskeletal conditions that moderately or severely impact walking
- Under 60 years old
- Do not have a diagnosis of PN with plantar sensory loss
- Untreated lymphedema
- Self-reported, untreated fractures in the foot and ankle
- Use of ankle-foot orthosis for ambulation that prevents donning of Walkasins
- Weight of more than 300 pounds
- Inability to perceive vibration from Walkasins Haptic Module
- Do not demonstrate balance impairments, defined as a Single-Leg Stance time of <23 seconds
Where in United States
- Brooks Rehabilitation CenterJacksonville, United StatesContact: Mark B Bowden, PhDTaking people
About the trial
What the trial wants to find out
The goal of this clinical trial is to investigate whether sensory stimulations from a neuroprosthesis device (Walkasins®) can increase physical activity and improve gait quality in persons with peripheral neuropathy (PN). The main question it aims to answer is whether Walkasins enhances habitual activity patterns in adults with peripheral neuropathy.
Read full original descriptionShow less
Participants will do the following as part of the study:
* Complete a sensation and balance assessment to determine eligibility for the study. * Answer questions about their medical history, physical function, balance confidence, and sleep. * Perform various balance and walking tasks on three separate occasions. One of the tests involves walking for six minutes without a cane or walker. * Wear an activPAL activity monitor for ten days on three separate occasions and return it to the researcher as directed. * Wear Walkasins for ten weeks as part of their daily routine. Walkasins consists of two parts: 1) an insole that fits inside the shoe and 2) a strap that secures around the ankle.
The group in the trial
- Walkasins UsersTreatment being tested
After the baseline visit and activity monitoring, users will receive Walkasins. They will use the device for 10 weeks during which they will also wear an activPAL activity monitor for ten days on at the beginning and end of their Walkasins use.
Treatment: External, lower limb sensory prosthesis
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Wearable Sensory Prostheses to Improve Neuromuscular Coordination, Walking Function, and Real-World Physical Activity
- Plain-language title
- Wearable Shoe Device to Improve Walking and Activity in Peripheral NeuropathyGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 13 November 2026.
- Record updated
- 25 June 2026